Výsledky vyhledávání - "Daniel Einhorn"

Akademický článek

Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone

Autor: Vivian A Fonseca, John B Buse, Julio Rosenstock, Richard E Pratley, Lawrence Blonde, Irina Bancos, Iulia Cristina Tudor, Ralph A DeFronzo, Richard J Auchus, Robert S Busch, James W Findling, Juan P Frias, Oksana Hamidi, Yehuda Handelsman, Andreas G Moraitis, Daniel Einhorn

Publikováno v: BMJ Open, Vol 14, Iss 7 (2024)

Introduction Even with recent treatment advances, type 2 diabetes (T2D) remains poorly controlled for many patients, despite the best efforts to adhere to therapies and lifestyle modifications. Although estimates vary, studies indicate that in >10% o

Externí odkaz: https://doaj.org/article/519af66c56274a5fb81b50cbc366808d

Zobrazit plný text záznamu

Akademický článek

Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®

Autor: Suzanne V. Arnold, Abhinav Goyal, Silvio E. Inzucchi, Darren K. McGuire, Fengming Tang, Sanjeev N. Mehta, Laurence S. Sperling, Thomas M. Maddox, Daniel Einhorn, Nathan D. Wong, Niklas Hammar, Peter Fenici, Kamlesh Khunti, Carolyn S. P. Lam, Mikhail Kosiborod

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 8 (2017)

BackgroundAlthough guidelines and performance measures exist for patients with diabetes mellitus, achievement of these metrics is not well known. The Diabetes Collaborative Registry® (DCR) was formed to understand the quality of diabetes mellitus ca

Externí odkaz: https://doaj.org/article/da64704e10a34351987ed85c7b1c817b

Zobrazit plný text záznamu

Fatty Kidney Disease: A New Renal And Endocrine Clinical Entity? Describing the Role of the Kidney in Obesity, Metabolic Syndrome, and Type 2 Diabetes

Autor: Christian W. Mende, Daniel Einhorn

Publikováno v: Endocrine Practice. 25:854-858

Objective: To determine whether fatty kidney disease deserves be designated as a distinct clinical entity similar to fatty liver disease. Methods: Analysis and interpretation of the literature in a novel conceptual framework. Results: The kidney cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c39bfe267f93a5acee81e3c32dcc741
https://doi.org/10.4158/ep-2018-0568

Zobrazit plný text záznamu

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary

Autor: Eliot A. Brinton, Michael H. Davidson, Matthew J. Budoff, Jeffrey I. Mechanick, Chris K. Guerin, Yehuda Handelsman, Vivian Fonseca, Sergio Fazio, Ronald M. Krauss, George Grunberger, Paul D. Rosenblit, Daniel Einhorn, Zachary T. Bloomgarden, Kathleen Wyne, Donald A. Smith, Paul S. Jellinger, Alan J. Garber

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 26(10)

The treatment of lipid disorders begins with lifestyle therapy to improve nutrition, physical activity, weight, and other factors that affect lipids. Secondary causes of lipid disorders should be addressed, and pharmacologic therapy initiated based o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f975b5cec5c598e5ccfd6c2468d0bf17
https://pubmed.ncbi.nlm.nih.gov/33471721

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání